Society Logo
Millie
Meet Millie, the Only Kangaroo in the Whole ME/CFS Universe!


Facebook


E-mail
Email the Society
Donations
Donations


ME/CFS AUSTRALIA (SA) INC

Registered Charity 698

Mailing address:
GPO Box 383,
Adelaide,
South Australia 5001

Office:
266 Port Road,
Hindmarsh,
South Australia 5007
Ph: (08) 8346 3237
('834 MECFS')

Office Hours:
Wednesdays, 10am-3pm

Support Line:
(Mondays and Thursdays,
10am-3pm)
Ph: (08) 8346 3237

SA country callers:
Ph: 1300 128 339
(local call)


FIBROMYALGIA HELP:
Contact
Fibromyalgia SA
at the
Arthritis Foundation of SA
118 Richmond Road,
Marleston 5033
Ph: (08) 8379 5711



ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.



Charity Direct

ME/CFS Australia (SA) Inc is a member of Charity Direct.



ourcommunity.com.auDonate online

Information and Support 2004 is an online appeal that aims to improve our Information and Support Line.

Read more…



Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

New York Times article on drug approved for Fibromyalgia

Tuesday 15 January 2008

Pain graphThe New York Times has published an article on a potential controversy involving a new drug,Lyrica, which was recently approved in the US for dealing with Fibromyalgia pain.

The article, written by Alex Berenson, begins:

“Fibromyalgia is a real disease. Or so says Pfizer in a new television advertising campaign for Lyrica, the first medicine approved to treat the pain condition, whose very existence is questioned by some doctors.”

Berenson goes on to state:

“For patient advocacy groups and doctors who specialize in fibromyalgia, the Lyrica approval is a milestone. They say they hope Lyrica and two other drugs that may be approved this year will legitimize fibromyalgia, just as Prozac brought depression into the mainstream.

But other doctors – including the one who wrote the 1990 paper that defined fibromyalgia but who has since changed his mind – say that the disease does not exist and that Lyrica and the other drugs will be taken by millions of people who do not need them.”

However, later in the article Berenson explains the use ofLyricafor Fibromyalgia:

“Because fibromyalgia patients typically do not respond to conventional painkillers like aspirin, drug makers are focusing on medicines like Lyrica that affect the brain and the perception of pain.”

You can read the full article here:

The New York Times: Drug Approved. Is Disease Real? (external link)

The New York Times runs a subscription service with its articles. If the above link no longer works, you can download the article here:

PDF

The New York Times: Drug Approved. Is Disease Real? (PDF, 324KB)

The Lyrica television commercial

Lyrica commercialThe television commercial forLyricacan be seen on theLyricawebsite:

www.lyrica.com (external link)

 


Arrow right

More Fibromyalgia News
Previous Previous Page